Management of Pulmonary Embolism During Central Line Placement

Initial Assessment and Management

The European Society of Cardiology recommends immediate anticoagulation with unfractionated heparin in patients with pulmonary embolism during central line placement, followed by risk stratification to guide further management 1
Assess hemodynamic stability immediately to distinguish between high-risk and non-high-risk pulmonary embolism, and provide oxygen supplementation to correct hypoxemia in patients with pulmonary embolism during central line placement 2
Initiate unfractionated heparin with weight-adjusted bolus injection without delay in patients with pulmonary embolism during central line placement 1
Consider bedside echocardiography to assess right ventricular function and help differentiate pulmonary embolism from other conditions like air embolism during central line placement 4
If central line is still in place, do not remove immediately as this could worsen the situation; consider removal after anticoagulation has been established in patients with pulmonary embolism during central line placement 5

The European Society of Cardiology recommends administering systemic thrombolytic therapy as first-line treatment for high-risk pulmonary embolism unless contraindicated 1
Consider surgical pulmonary embolectomy if thrombolysis is contraindicated or has failed in patients with high-risk pulmonary embolism 1
Administer norepinephrine and/or dobutamine for hemodynamic support in patients with high-risk pulmonary embolism 1
In cases of refractory circulatory collapse, extracorporeal membrane oxygenation (ECMO) may be considered in combination with surgical embolectomy or catheter-directed treatment in patients with high-risk pulmonary embolism 1

Rule out air embolism, which can present similarly to thrombotic pulmonary embolism during central line procedures, and administer 100% oxygen if air embolism is suspected 4
Position patient in left lateral decubitus position to prevent air from migrating to the pulmonary artery if air embolism is suspected 4
If the central line is still in place, attempt to aspirate air bubbles if air embolism is suspected 4

Administer therapeutic anticoagulation for at least 3 months to all patients with pulmonary embolism 3
Consider discontinuing anticoagulation after 3 months in patients with first pulmonary embolism secondary to a major transient risk factor, such as central line placement 3

Superior vena cava (SVC) filter placement should be limited to patients with a contraindication to anticoagulation therapy or those with thrombus progression despite adequate anticoagulation, with a complication rate of 3.8% 5
Note that SVC filter placement is technically more difficult than inferior vena cava filter placement and carries risk of severe complications, including cardiac tamponade, aortic perforation, and recurrent pneumothorax 5

Do not delay anticoagulation while awaiting diagnostic confirmation in patients with suspected pulmonary embolism 3
Be aware that pulmonary hemorrhage is a rare but important complication that can occur during catheter-directed thrombolysis, with a risk that necessitates careful patient selection and monitoring 6